SEC Tracker
Get the app

Onconetix ONCO

Onconetix amends share exchange agreement

Form
8-K
Filed
Importance
Routine
  1. Net Cash less than $12.5 million triggers 95% ownership by Seller
  2. Net Cash definition includes Grid Promissory Note balance
  3. End Date extended to March 31, 2027

Written from the 8-K on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Onconetix files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Enveric Biosciences ENVB public float $4M, Jun 30, 2025
  2. Polomar Health Services PMHS public float $4M, Jun 30, 2025
  3. Q/C Technologies QCLS public float $4M, Jun 30, 2025
  4. Integrated Biopharma INBP public float $3M, Dec 31, 2025
  5. Jaguar Health JAGX public float $4M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.